يعرض 1 - 10 نتائج من 21 نتيجة بحث عن '"Mohamed-Adnène Laatiri"', وقت الاستعلام: 1.17s تنقيح النتائج
  1. 1
  2. 2
    دورية أكاديمية
  3. 3
    دورية أكاديمية
  4. 4
  5. 5
  6. 6
    دورية أكاديمية
  7. 7
  8. 8
  9. 9
  10. 10

    المساهمون: Hôpital Universitaire Aziza Othmana [Tunis], Hôpital militaire de Tunis, Hedi Chaker Hospital [Sfax], CHU Farhat Hached [Sousse], Laboratoire d'hématologie moléculaire et cellulaire (LR11IPT07), Institut Pasteur de Tunis, Réseau International des Instituts Pasteur (RIIP)-Réseau International des Instituts Pasteur (RIIP), Hôpital La Rabta [Tunis], CHU Fattouma Bourguiba [Monastir] (HFB), Centre National de Greffe de la Moëlle osseuse Tunis (CNGMO)

    المصدر: Annals of Hematology
    Annals of Hematology, Springer Verlag, 2018, 97 (4), pp.597--604. ⟨10.1007/s00277-017-3224-2⟩

    مصطلحات موضوعية: Male, MESH: Leukemia, Myeloid, Accelerated Phase/drug therapy, MESH: Splenomegaly/prevention & control, MESH: Tunisia/epidemiology, Clinical practice, Tyrosine-kinase inhibitor, 0302 clinical medicine, MESH: Leukemia, Myeloid, Chronic-Phase/drug therapy, MESH: Aged, 80 and over, MESH: Child, Epidemiology, Medicine, MESH: Imatinib Mesylate/therapeutic use, Practice Patterns, Physicians', Child, Survey, CML, Aged, 80 and over, MESH: Aged, Hematology, MESH: Middle Aged, Myeloid leukemia, General Medicine, MESH: Follow-Up Studies, Middle Aged, Prognosis, 3. Good health, Tumor Burden, Management, Leukemia, MESH: Young Adult, MESH: Imatinib Mesylate/adverse effects, 030220 oncology & carcinogenesis, Child, Preschool, MESH: Survival Analysis, Leukemia, Myeloid, Chronic-Phase, MESH: Leukemia, Myeloid, Chronic-Phase/epidemiology, Imatinib Mesylate, MESH: Leukemia, Myeloid, Accelerated Phase/pathology, Female, MESH: Antineoplastic Agents/therapeutic use, Sokal Score, medicine.drug, Adult, medicine.medical_specialty, Tunisia, Adolescent, medicine.drug_class, Antineoplastic Agents, Leukemia, Myeloid, Accelerated Phase, MESH: Prognosis, 03 medical and health sciences, Young Adult, Internal medicine, MESH: Leukemia, Myeloid, Chronic-Phase/diagnosis, Humans, MESH: Leukemia, Myeloid, Chronic-Phase/pathology, Adverse effect, Protein Kinase Inhibitors, Aged, Retrospective Studies, MESH: Adolescent, MESH: Humans, business.industry, MESH: Child, Preschool, Imatinib, MESH: Adult, MESH: Retrospective Studies, MESH: Protein Kinase Inhibitors/adverse effects, medicine.disease, Survival Analysis, MESH: Male, MESH: Protein Kinase Inhibitors/therapeutic use, MESH: Splenomegaly/pathology, MESH: Leukemia, Myeloid, Accelerated Phase/epidemiology, Splenomegaly, MESH: Practice Patterns, Physicians', MESH: Leukemia, Myeloid, Accelerated Phase/diagnosis, MESH: Splenomegaly/etiology, business, MESH: Tumor Burden/drug effects, MESH: Female, [SDV.MHEP]Life Sciences [q-bio]/Human health and pathology, 030215 immunology, Follow-Up Studies, MESH: Antineoplastic Agents/adverse effects